PAR paradigm biopharmaceuticals limited..

research reports and media, page-4369

  1. 2,276 Posts.
    lightbulb Created with Sketch. 837
    “then there is a wonderful amount of evidence in the public domain for any decent law firm to pursue a class action on behalf of investors”

    “PR and co. have actually now spoken too formally of partnerships for a class action to not occur if one did not ensue FDA clearance”

    Sorry, I can’t find a might or even an implied one in either of the above two statements from you.

    BTW, There is no case to answer regardless.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
42.0¢
Change
-0.020(4.55%)
Mkt cap ! $166.9M
Open High Low Value Volume
44.5¢ 44.5¢ 41.5¢ $271.6K 637.8K

Buyers (Bids)

No. Vol. Price($)
2 5960 42.0¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 3696 1
View Market Depth
Last trade - 16.10pm 16/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.